See the source article by following the link below:
The FDA is holding a meeting to consider approving Cannabidiol - a cannabinoid prepared from the Cannabis sativa L. plant - for a set of severe childhood seizure disorders.
The FDA is holding a meeting to consider approving Cannabidiol - a cannabinoid prepared from the Cannabis sativa L. plant - for a set of severe childhood seizure disorders.
No comments:
Post a Comment